FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904312786> ?p ?o ?g. }

• W2904312786 endingPage "e13344" @default.
• W2904312786 startingPage "e13344" @default.
• W2904312786 abstract "Abstract Background: Lymph node detection in prostate cancer is challenging and critical to determine treatment policy. Choline PET/CT (positron emission tomography/computed tomography) and magnetic resonance imaging (MRI) have been used for the evaluation of lymph node metastasis in patients with prostate cancer for the past decade. However, only limited patients underwent direct comparison studies. Purpose: To evaluate the diagnostic performance of choline PET/CT compared with MRI imaging for detecting lymph node metastases in prostate cancer patients. Material and Methods: Relevant English-language articles published before February 2018 were searched in PubMed database, Embase database, and Cochrane Library databases search using the keywords: (Prostate Neoplasm OR Prostate Cancer OR prostate carcinoma) and (Lymph Node) and (PET/CT OR positron emission tomography/computed tomography) and (choline or 2-hydroxy- N , N , N -trimethylethanaminium) and (magnetic resonance imaging OR MRI). Articles were included that directly compare the diagnostic performance and clinical utility of choline PET/CT and MRI for detecting lymph node metastases in prostate cancer patients. Study quality was assessed with QUADAS criteria. Analyses were performed on a per patient and a per node basis. The pooled sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (LR+), and negative likelihood ratio (LR−) were calculated using Meta-Disc 1.4 software. Summary receiver-operating characteristic (SROC) curves constructed. Results: A total of 362 patients from 8 studies involving fulfilled the inclusion criteria. On patient-based analysis, the pooled sensitivity, specificity, and DOR with a 95% confidence interval (CI) for choline PET/CT imaging were 0.59 (95%CI, 0.50–0.67), 0.92 (95%CI, 0.87–0.96), 17.37 (95%CI, 4.42–68.33), and for MRI imaging, they were 0.52 (95%CI, 0.44–0.61), 0.87 (95%CI, 0.81–0.92), 6.05 (95%CI, 3.09–11.85), respectively. On node-based, the corresponding values for choline PET/CT imaging were 0.51 (95%CI, 0.46–0.57), 0.99 (95%CI, 0.98–0.99), 65.55 (95%CI, 23.55–182.45), and for MRI imaging, they were 0.39 (95%CI, 0.34–0.44), 0.97 (95%CI, 0.96–0.97), 15.86 (95%CI, 8.96–28.05), respectively. Conclusion: Choline PET/CT performed better than MRI imaging in evaluating the lymph nodes metastasis of prostate cancer patients and had the potential to be broadly applied in clinical practice." @default.
• W2904312786 created "2018-12-22" @default.
• W2904312786 creator A5014091064 @default.
• W2904312786 creator A5022888334 @default.
• W2904312786 creator A5026429037 @default.
• W2904312786 creator A5047191423 @default.
• W2904312786 creator A5049692788 @default.
• W2904312786 creator A5071642159 @default.
• W2904312786 date "2018-12-01" @default.
• W2904312786 modified "2023-09-30" @default.
• W2904312786 title "Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer" @default.
• W2904312786 cites W1566558399 @default.
• W2904312786 cites W1971005131 @default.
• W2904312786 cites W1971596590 @default.
• W2904312786 cites W1977265573 @default.
• W2904312786 cites W1980053751 @default.
• W2904312786 cites W1981437338 @default.
• W2904312786 cites W2028055007 @default.
• W2904312786 cites W2031729386 @default.
• W2904312786 cites W2066758446 @default.
• W2904312786 cites W2073207929 @default.
• W2904312786 cites W2090790817 @default.
• W2904312786 cites W2095183081 @default.
• W2904312786 cites W2099169865 @default.
• W2904312786 cites W2107638293 @default.
• W2904312786 cites W2117441254 @default.
• W2904312786 cites W2123161437 @default.
• W2904312786 cites W2124586180 @default.
• W2904312786 cites W2125245370 @default.
• W2904312786 cites W2139882239 @default.
• W2904312786 cites W2145187141 @default.
• W2904312786 cites W2145801780 @default.
• W2904312786 cites W2149269178 @default.
• W2904312786 cites W2158334167 @default.
• W2904312786 cites W2169160087 @default.
• W2904312786 cites W2212154793 @default.
• W2904312786 cites W2235523093 @default.
• W2904312786 cites W2254015231 @default.
• W2904312786 cites W2318460967 @default.
• W2904312786 cites W2470836458 @default.
• W2904312786 cites W2511949746 @default.
• W2904312786 cites W2601856579 @default.
• W2904312786 cites W2754052413 @default.
• W2904312786 cites W2765650591 @default.
• W2904312786 cites W2769093586 @default.
• W2904312786 cites W2776384280 @default.
• W2904312786 cites W2776414480 @default.
• W2904312786 cites W2784065990 @default.
• W2904312786 cites W2793313842 @default.
• W2904312786 cites W2807085990 @default.
• W2904312786 doi "https://doi.org/10.1097/md.0000000000013344" @default.
• W2904312786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6320103" @default.
• W2904312786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30557983" @default.
• W2904312786 hasPublicationYear "2018" @default.
• W2904312786 type Work @default.
• W2904312786 sameAs 2904312786 @default.
• W2904312786 citedByCount "11" @default.
• W2904312786 countsByYear W29043127862019 @default.
• W2904312786 countsByYear W29043127862020 @default.
• W2904312786 countsByYear W29043127862021 @default.
• W2904312786 countsByYear W29043127862023 @default.
• W2904312786 crossrefType "journal-article" @default.
• W2904312786 hasAuthorship W2904312786A5014091064 @default.
• W2904312786 hasAuthorship W2904312786A5022888334 @default.
• W2904312786 hasAuthorship W2904312786A5026429037 @default.
• W2904312786 hasAuthorship W2904312786A5047191423 @default.
• W2904312786 hasAuthorship W2904312786A5049692788 @default.
• W2904312786 hasAuthorship W2904312786A5071642159 @default.
• W2904312786 hasBestOaLocation W29043127861 @default.
• W2904312786 hasConcept C121608353 @default.
• W2904312786 hasConcept C126322002 @default.
• W2904312786 hasConcept C126838900 @default.
• W2904312786 hasConcept C142724271 @default.
• W2904312786 hasConcept C143409427 @default.
• W2904312786 hasConcept C157481446 @default.
• W2904312786 hasConcept C2775842073 @default.
• W2904312786 hasConcept C2776235491 @default.
• W2904312786 hasConcept C2780192828 @default.
• W2904312786 hasConcept C2780849966 @default.
• W2904312786 hasConcept C2989005 @default.
• W2904312786 hasConcept C3020132585 @default.
• W2904312786 hasConcept C44249647 @default.
• W2904312786 hasConcept C58471807 @default.
• W2904312786 hasConcept C71924100 @default.
• W2904312786 hasConceptScore W2904312786C121608353 @default.
• W2904312786 hasConceptScore W2904312786C126322002 @default.
• W2904312786 hasConceptScore W2904312786C126838900 @default.
• W2904312786 hasConceptScore W2904312786C142724271 @default.
• W2904312786 hasConceptScore W2904312786C143409427 @default.
• W2904312786 hasConceptScore W2904312786C157481446 @default.
• W2904312786 hasConceptScore W2904312786C2775842073 @default.
• W2904312786 hasConceptScore W2904312786C2776235491 @default.
• W2904312786 hasConceptScore W2904312786C2780192828 @default.
• W2904312786 hasConceptScore W2904312786C2780849966 @default.
• W2904312786 hasConceptScore W2904312786C2989005 @default.
• W2904312786 hasConceptScore W2904312786C3020132585 @default.
• W2904312786 hasConceptScore W2904312786C44249647 @default.
• W2904312786 hasConceptScore W2904312786C58471807 @default.

• next